Caris Life Sciences

Oncology

pharmaphorum podcast Episode 198a - Eric Matthews

Advancing the frontiers of cancer diagnostics: Post-ASCO wit...

Post-ASCO 2025, Eric Matthews, chief business officer at Caris Life Sciences, discusses advancing the frontier of cancer diagnostics and treatment.

News

Caris swells its planned IPO, seeking $5.7bn valuation

AI-powered techbio firm Caris Life Sciences has raised the target price for its IPO, pointing to strong demand among investors.

News

Merck taps Caris’ AI expertise in ADC-focused alliance

Germany’s Merck KGaA has partnered with techbio company Caris Discovery in a $1.4 billion alliance that will apply artificial intelligence to the design of antibody-drug c

Advancing the frontiers of cancer diagnostics: Post-ASCO wit...

Caris swells its planned IPO, seeking $5.7bn valuation

Merck taps Caris’ AI expertise in ADC-focused alliance

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks